agilon health, inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- agilon health, inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $5.49M, a 4894.55% increase year-over-year.
- agilon health, inc. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $0.00.
- agilon health, inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- agilon health, inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $110.00K, a 35.67% decline year-over-year.
- agilon health, inc. stock issued during period, value, stock options exercised for fiscal 2025 was $110.00K, a 96.01% decline from fiscal 2024.
- agilon health, inc. stock issued during period, value, stock options exercised for fiscal 2024 was $2.76M, a 79.89% decline from fiscal 2023.
- agilon health, inc. stock issued during period, value, stock options exercised for fiscal 2023 was $13.71M, a 59.53% decline from fiscal 2022.
- agilon health, inc. stock issued during period, value, stock options exercised for fiscal 2022 was $33.89M, a 87.37% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $5.49M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $110.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | |
| 2025-06-30 | $110.00K 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.76M 10-K · filed 2026-02-25 |
| 2024-09-30 | $132.00K 10-Q · filed 2025-11-04 | $3.20M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $171.00K 10-Q · filed 2025-08-04 | $5.79M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $2.46M 10-Q · filed 2025-05-06 | $6.55M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $13.71M 10-K · filed 2026-02-25 |
| 2023-09-30 | $2.72M 10-Q · filed 2024-11-07 | $15.69M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $928.00K 10-Q · filed 2024-08-06 | $23.36M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $9.62M 10-Q · filed 2024-05-07 | $28.75M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $33.89M 10-K · filed 2025-02-25 |
| 2022-09-30 | $10.39M 10-Q · filed 2023-11-02 | $47.94M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $6.32M 10-Q · filed 2023-08-03 | $38.61M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $14.76M 10-Q · filed 2023-05-09 | $32.68M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $16.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $18.09M 10-K · filed 2024-02-27 |
| 2021-09-30 | $1.05M 10-Q · filed 2022-11-03 | $1.61M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $386.00K 10-Q · filed 2022-08-04 | $1.05M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $165.00K 10-Q · filed 2022-05-05 | $975.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $814.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $497.00K 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $313.00K 10-Q · filed 2021-08-04 | |
| 2020-03-31 | $2.00K 10-Q · filed 2021-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |